The Three Metabolic Patient Types and How to Identify Them in Your Practice

functional medicine integrative medicine metabolic health nurse practitioner Jun 19, 2026
Nurse practitioner reviewing metabolic lab panels to identify patient phenotype

Not every metabolic patient looks the same.

You already know this. The patient who is 60 pounds overweight with an A1c of 6.8 is not the same clinical picture as the patient who is 15 pounds overweight with normal labs and severe fatigue. And neither of them is the same as the lean patient with a waist circumference that does not match her BMI and a cholesterol panel that keeps getting worse despite her clean diet.

Conventional medicine treats all three the same way. Lifestyle counseling. Maybe metformin. Watch and wait.

Integrative clinical thinking identifies which metabolic pattern is driving each presentation and intervenes upstream of the consequences.

Here are the three metabolic patient types you are seeing in your practice right now whether you have named them or not.

Patient Type One: The Insulin-Driven Patient

This is your most common metabolic patient. She has been accumulating insulin resistance for years. Her fasting glucose looks acceptable. Her A1c is in the pre-diabetic range or just below it. Her lipids show elevated triglycerides and low HDL. She carries weight in her midsection. She is fatigued after meals and craves carbohydrates in the afternoon.

Her labs:

  • Fasting insulin above 12 to 15 microunits per milliliter
  • HOMA-IR above 2.5
  • Triglycerides above 150
  • HDL below 50
  • Fasting glucose 95 to 110

What drives her: chronic carbohydrate excess relative to her metabolic capacity, inadequate muscle mass, sedentary patterns, and often poor sleep. Her pancreas has been compensating for years and the compensation is starting to fail.

What she needs: carbohydrate quality and timing intervention, a specific resistance training prescription, sleep optimization, and in moderate to severe cases berberine or metformin alongside lifestyle intervention.

What she does not need: another conversation about eating less and moving more without a framework for how and why.

Patient Type Two: The Cortisol-Driven Patient

This patient is often leaner than Type One but her metabolic picture is equally disrupted. She may not be significantly overweight. Her fasting glucose and A1c may be completely normal. She presents with fatigue, poor sleep, midsection weight gain that does not match her overall body composition, and weight loss resistance that defies her caloric intake.

Her labs:

  • Morning cortisol above 18 to 22 mcg/dL
  • Fasting insulin mildly elevated, often 8 to 14
  • HOMA-IR borderline, often 1.8 to 2.5
  • Normal fasting glucose
  • Normal A1c
  • Often mildly elevated CRP

What drives her: chronic psychological or physiological stress, poor sleep quality, high-intensity exercise in an already elevated cortisol state, and inadequate recovery. Her HPA axis is dysregulated and her metabolism is adapting to a threat signal that never turns off.

What she needs: sleep intervention first, exercise prescription shifted toward resistance training and low-intensity movement, adaptogenic support with ashwagandha or phosphatidylserine, and meal timing that supports the natural cortisol decline through the morning.

What she does not need: a higher-intensity exercise prescription or a more aggressive caloric deficit. Both make the underlying pattern worse.

Patient Type Three: The Inflammatory-Metabolic Patient

This patient is the most complex and the most commonly missed. Her metabolic markers may look relatively controlled. Her weight may be moderate. But her inflammatory burden is driving metabolic dysfunction across multiple systems simultaneously.

Her labs:

  • Elevated hsCRP, often above 2.0 and sometimes above 5.0
  • Elevated fasting insulin despite moderate weight
  • Elevated homocysteine
  • Low vitamin D
  • Often abnormal omega-6 to omega-3 ratio on a micronutrient panel
  • Sometimes mildly elevated ferritin as an acute phase reactant

What drives her: gut dysbiosis feeding systemic inflammation, dietary pattern high in refined oils and ultra-processed foods, chronic low-grade infection or immune activation, environmental toxic burden, and often significant psychological stress compounding the inflammatory load.

What she needs: gut assessment and intervention first, dietary pattern shift toward anti-inflammatory foods, targeted supplementation with omega-3 fatty acids, vitamin D, and magnesium, and investigation of the upstream inflammatory driver rather than just management of downstream markers.

What she does not need: statin therapy as the first intervention for elevated cholesterol driven by inflammation rather than lipid metabolism dysregulation.

Why Phenotyping Your Metabolic Patients Changes Everything

When you treat every metabolic patient the same way you get inconsistent results. Some patients respond. Others do not. And without a phenotyping framework you have no systematic way to understand why.

When you identify which pattern is driving the presentation you can intervene specifically. The insulin-driven patient and the cortisol-driven patient both have weight loss resistance but they need completely different interventions. Giving the cortisol-driven patient a more aggressive caloric deficit and an intense exercise program makes her worse. Giving the insulin-driven patient adaptogens without addressing carbohydrate quality misses the primary driver.

Same chief complaint. Completely different clinical picture. Completely different intervention.

That is what a metabolic clinical framework gives you.

Where to Start in Your Practice

You do not need to overhaul your visit structure to begin phenotyping your metabolic patients. Add these three labs to your standard metabolic workup:

  • Fasting insulin alongside fasting glucose for HOMA-IR calculation
  • Morning cortisol
  • hsCRP

Together these three results tell you whether you are looking at an insulin-driven pattern, a cortisol-driven pattern, an inflammatory-metabolic pattern, or a combination of all three. Three labs. A completely different clinical conversation. And a patient who finally gets an answer that makes sense of what she has been experiencing for years.

If you want the complete metabolic clinical framework including phenotyping, lab interpretation, and intervention protocols for all three patient types, the Metabolic Health and Insulin Resistance course at BridgeWell builds this from the ground up for NPs.

Learn more here: https://www.bridgewelled.com/metabolic-medicine-bundle

Not ready for a course? Start with the BridgeWell Clinical Case Series: three real patient cases that show you integrative clinical thinking in action.

Access the case series here: https://www.bridgewelled.com/case-series